Cladrim 10mg Injection

About

Cladrim 10mg Injection contains Cladribine, a purine nucleoside analog that acts as an antimetabolite. It is a potent immunosuppressive and cytotoxic agent, primarily used in the treatment of certain hematological malignancies and autoimmune diseases. Cladribine is incorporated into DNA, leading to DNA strand breaks and inhibition of DNA synthesis and repair, particularly in lymphocytes and monocytes. This selective toxicity to lymphocytes makes it highly effective in conditions characterized by an overproduction or hyperactivity of these cells.

Its mechanism of action results in prolonged lymphopenia, which is therapeutically beneficial in diseases like hairy cell leukemia and multiple sclerosis. The drug is administered intravenously, and its precise dosing and administration require careful medical supervision. Due to its immunosuppressive effects, patients receiving Cladribine are at an increased risk of infections, necessitating close monitoring throughout the treatment period.

Uses

• Hairy Cell Leukemia (HCL)
• Multiple Sclerosis (MS)
• Chronic Lymphocytic Leukemia (CLL)
• Non-Hodgkin's Lymphoma

Directions For Use

This medicine is administered intravenously by a qualified healthcare professional.

Dosage and duration will be determined by your doctor based on your condition.

Benefits

• Highly effective in hairy cell leukemia
• Disease-modifying treatment for multiple sclerosis
• Reduces relapse rates in MS patients
• Offers prolonged remission in HCL
• Can be administered in short courses for MS
• Targets specific immune cells effectively

Side Effects

• Myelosuppression (low blood counts)
• Fever and chills
• Infections (bacterial, viral, fungal)
• Fatigue and weakness
• Headache
• Nausea and vomiting
• Skin rash
• Injection site reactions
• Immunosuppression
• Neurological effects (paresthesia, dizziness)
• Elevated liver enzymes
• Opportunistic infections

Safety Measures

• Alcohol - Avoid alcohol consumption during treatment with Cladrim 10mg Injection as it may increase the risk of side effects or liver toxicity.
• Pregnancy - Cladrim 10mg Injection is contraindicated in pregnancy due to its teratogenic potential. Women of childbearing potential must use effective contraception during and for at least 6 months after treatment.
• Breastfeeding - Breastfeeding is contraindicated during treatment with Cladrim 10mg Injection and for at least 6 months after the last dose due to potential harm to the infant.
• Liver - Use with caution in patients with hepatic impairment. Liver function should be monitored closely, and dose adjustments may be necessary.
• Kidney - Use with caution in patients with renal impairment. Dose adjustments may be required, and kidney function should be monitored due to potential for increased toxicity.
• Lung - Rare cases of interstitial pneumonitis have been reported. Monitor for new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.